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Key points summary
• Maternal high-fructose (HF) induces programmed hypertension in adult offspring.
• Early aliskiren administration prevents HF-induced hypertension in both sexes of adult
offspring.
• HF regulates RAS components in the offspring kidney in a sex-specific manner.
• HF alters renal transcriptome, with female offspring being more sensitive.
• Deprogramming strategy to prevent hypertension might be sex-specific.
Background: Maternal high fructose (HF) intake induced renal programming and
hypertension in male adult offspring. We examined whether maternal HF intake causes
programmed hypertension and whether aliskiren administration confers protection
against the process in a sex-specific manner, with a focus on the transcriptome
changes in the kidney using next-generation RNA sequencing (NGS) technology and
renin-angiotensin system (RAS).
Methods: Pregnant Sprague—Dawley rats received regular chow or chow
supplemented with 60% fructose throughout pregnancy and lactation. Offspring were
assigned to six groups: male control, male HF (MHF), MHF+Aliskiren, female control,
female HF (FHF), and FHF+Aliskiren. Oral aliskiren 10 mg/kg/day was administered via
gastric gavage between 2 and 4 weeks of age. Rats were sacrificed at 12 weeks of age.
Results: Maternal HF intake induced programmed hypertension in 12-week-old
offspring of both sexes. HF regulated renal transcriptome and RAS components in the
offspring kidney in a sex-specific manner. Aliskiren administration prevented HF-induced
programmed hypertension in both sexes of adult offspring. Aliskiren administration
increased ACE2 andMAS protein levels in female kidneys exposed tomaternal HF intake.
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Conclusion: Maternal HF induced programmed hypertension in both sexes of adult
offspring, which was sex-specifically mitigated by early aliskiren administration. Better
understanding of the sex-dependent mechanisms that underlie maternal HF-induced
renal programming will help develop a novel sex-specific strategy to prevent programmed
hypertension.
Keywords: aliskiren, fructose, hypertension, renin-angiotensin system, sex differences
INTRODUCTION
Fructose is a natural sugar found in many fruits. Fructose
consumption has dramatically increased since the introduction
of commercially produced high fructose corn syrup sweeteners.
The total per capita use of sweeteners increased by 86% between
1909 and 1997 (Gross et al., 2004). An increase in fructose
consumption over the past 2 decades has been linked to a
rise in metabolic syndrome comorbidities, such as hypertension
(Johnson et al., 2007). Maternal high fructose (HF) intake can
lead to hypertension in adult offspring, a phenomenon referred
to as developmental programming (Ojeda et al., 2008; Paixão
and Alexander, 2013). A shift in the therapeutic approach
from the adult to earlier states that precede the development
has occurred, a concept called reprogramming (Tain and Joles,
2015b). Although several organs control blood pressure (BP),
the developing kidney is particularly vulnerable to the maternal
insults. Thus, renal programming has been identified as a
driving mechanism of programmed hypertension (Paixão and
Alexander, 2013; Tain et al., 2015a; Tain and Joles, 2015b).
Previously, we have reported that maternal HF intake induced
programmed hypertension in adult male offspring, which can
be reprogrammed by early intervention (Tain et al., 2014,
2015d).
Both human and experimental animal evidence shows
that hypertension is more common in males compared with
females (Sandberg and Ji, 2012) and sex differences also have
been observed in some models of programmed hypertension
(Sandberg and Ji, 2012; Aiken and Ozanne, 2013). However, it
is unclear whether sex differences exist in maternal HF-induced
programmed hypertension and reprogramming strategy. Sex
differences were reported to be important determinants of the
specific pathologies that develop in association with HF intake
(Sharma et al., 2015). Sex differences also have been reported
in kidney gene expression in F344 rats (Kwekel et al., 2013).
Thus, identification of the underlying sex-specific mechanisms
could provide novel reprogramming strategy to reach maximal
optimization in both sexes. Since nephrogenesis occurs from late
gestation to postnatal week 1 in rodents, we therefore employed
the whole-genome next-generation RNA sequencing (NGS) to
quantify the abundance of RNA transcripts in the kidney of
Abbreviations: ACE2, angiotensin converting enzyme 2; ACEI, ACE inhibitor;
ARB, angiotensin receptor blocker; AT2R, angiotensin II type 2 receptor; DEG,
differential expressed gene; FPKM, fragment per kilobase of exon per million
mapped fragment; HF, high-fructose; KEGG, Kyoto Encyclopedia of Genes and
Genomes; NGS, next-generation sequencing; RAS, renin-angiotensin system; SD,
Sprague-Dawley.
1-week old offspring of both sexes that had maternal exposure
to HF intake, to identify the primary programmed changes.
The renin-angiotensin system (RAS) plays a fundamental role
in the regulation of nephrogenesis and blood pressure (BP)
control. Treating the young offspring with an ACE inhibitor
(ACEI) captopril, angiotensin receptor blocker (ARB) losartan,
or renin inhibitor aliskiren between 2 and 4 weeks of age has
been reported to offset the effects of developmental programming
on BP. These findings support the proposal that targeting the
RAS might prevent programmed hypertension (Sherman and
Langley-Evans, 1998, 2000; Hsu et al., 2015). The RAS cascade
starts with the release of renin in the kidney and sex differences
exist in renal RAS expression (Te Riet et al., 2015). The study was
therefore designed to address two specific goals: First, to examine
if whether early postnatal aliskiren administration can prevent
programmed hypertension caused by maternal HF intake in a
sex-specific manner; Second, to analyze the renal transcriptome
and capture candidate genes and pathways in the offspring kidney
exposed to maternal HF intake using NGS approach.
MATERIALS AND METHODS
Experimental Design
This study was approved by the Institutional Animal Care
and Use Committee of the Kaohsiung Chang Gung Memorial
Hospital. Experimental animals were treated according to the
guidelines of the US National Institutes of Health. Virgin
Sprague-Dawley (SD) rats (age, 12–16 weeks) obtained from
BioLASCO Taiwan Co., Ltd. (Taipei, Taiwan) were housed in
a facility accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International. Rats
were exposed to 12-h light/12-h dark photoperiod. Male SD rats
were caged with female rats until mating was confirmed by the
presence of a vaginal plug. Male rats were removed after mating
was confirmed.
Pregnant SD rats received regular chow (N = 6) or chow
supplemented with 60% fructose throughout pregnancy and
lactation (N = 6) (Tain et al., 2014). After birth, each litter
was left with the mother until weaning; pups were not weighed
at birth to prevent maternal rejection. After birth, litters were
culled to give equal numbers of males and females for a total
of eight pups to standardize the received quantity of milk and
maternal pup care. Three male and three female offspring from
each group (control and HF) were killed at 1 week of age.
Their kidneys were isolated for NGS analysis. The remaining
offspring were assigned to 6 groups (N = 7/group): male control
(MC), male HF (MHF), MHF+Aliskiren, female control (FC),
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female HF (FHF), and FHF+Aliskiren. Male and female HF
offspring in aliskiren groups received oral aliskiren 10 mg/kg/day
via gastric gavage (Novartis Pharmaceutical, New York, USA)
between 2 and 4 weeks of age. Unlike nephrogenesis in humans,
which is completed at 38 gestational weeks it continues into the
postnatal weeks 1–2 in rodents. Thus, blockade of the RAS to
prevent the programmed hypertension cannot start early until
the completion of nephrogenesis in the rodent models (Sherman
and Langley-Evans, 1998, 2000; Hsu et al., 2015). The dose of
aliskiren used here was based on our previous studies conducted
in rats (Tain et al., 2011; Hsu et al., 2015). BP was measured
in conscious rats at 3, 4, 8, and 12 weeks of age by using an
indirect tail-cuff method (BP-2000; Visitech Systems, Inc., Apex,
NC, USA) (Tain et al., 2014). For each rat, five measurements
were recorded at each time point. The average of values from
three stable measurements was taken. Offspring were euthanized
by an i.p. overdose of pentobarbital at 12 week of age. The
midline of the abdomen was opened, and the intestines were
displaced laterally to allow visualization of the aorta. The aorta
was dissected from the adjacent vena cava, connective tissue, and
fat. The aorta was cannulated with a 20- to 23-gauge butterfly
needle, heparinized blood samples were collected, the vena cava
was cut, and PBS was perfused until the kidneys were blanched.
Perfused kidneys were harvested, decapsulated, divided into
cortex and medulla, flash frozen in liquid nitrogen, and stored
at−80◦C freezer for further analysis.
Next-Generation Sequencing and Analysis
Kidney cortex samples (n = 3/group) were used for RNA next-
generation sequencing (NGS) (Welgene Biotech Co., Ltd., Taipei,
Taiwan) using methods described previously (Tain et al., 2015d).
Briefly, purified RNAwas quantified at OD260nm by using a ND-
1000 spectrophotometer (Nanodrop Technology, Wilmington,
DE, USA) and qualitated by using a Bioanalyzer 2100 (Agilent
Technologies, Inc., Santa Clara, CA, USA) with RNA 6000
labchip kit (Agilent Technologies, Inc.). Library construction was
performed using the Solexa platform (Illumina, San Diego, CA,
USA). The sequence was directly determined by sequencing-by-
synthesis technology using the TruSeq SBS Kit (Illumina). Raw
sequences were obtained using the Illumina Pipeline software
bcl2fastq v2.0 (Illumina), which was expected to generate 30
million reads per sample. Gene expression was quantified as
fragment per kilobase of exon per million mapped fragment
(FPKM). The cuffdiff tool (Trapnell et al., 2013) was run to
calculate expression changes and associated q values (P-values
adjusted for false discovery rate) for each gene between MC,
MHF, FC, and FHF group. The output files of cuffdiff were
further annotated by adding gene functional descriptions and
Gene Ontology (GO) classifications. GO analysis for significant
genes was performed using Kyoto Encyclopedia of Genes and
Genomes (KEGG) and NIH DAVID Bioinformatics Resources
6.7 (NIH, Bethesda, MD, USA) to identify regulated biological
themes (Dennis et al., 2003). GO term enrichment and fold
enrichment or depletion for gene lists of significantly up- and
down-regulated genes in kidney were determined. The reference
genome and gene annotations were retrieved from Ensembl
database.
Quantitative Real-Time Polymerase Chain
Reaction
RNA was extracted using TRIzol reagent, treated with DNase I
(Ambion, Austin, TX, USA) to remove DNA contamination, and
reverse transcribed using random primers (Invitrogen, Carlsbad,
CA, USA). Control RT reactions were performed by omitting
RT enzyme. RNA concentration and quality were checked by
measuring optical density at 260 and 280 nm. Complementary
DNA was synthesized using M-MLV Reverse Transcriptase
(Invitrogen). Two-step quantitative real-time polymerase chain
reaction (PCR) was performed using QuantiTect SYBR Green
PCR Kit (Qiagen, Valencia, CA, USA) and iCycler iQ Multi-
Color Real-Time PCR Detection System (Bio-Rad, Hercules,
CA, USA). Components of the RAS were analyzed including
renin (Ren), prorenin receptor (Atp6ap2), angiotensinogen (Agt),
angiotensin-converting enzyme (Ace),Ace2, angiotensin II type 1
(Agtr1a) receptor and 2 receptor (Agtr1b), and angiotensin (1–7)
MAS receptor (Mas1). The 18S rRNA gene (Rn18s) was used as a
reference. Sequences of primers used in this study are provided
in Supplementary Table 1. Primer efficiency between 1.8 and
2.2 was acceptable. All the samples were examined in duplicate.
Comparative threshold cycle (CT) method was used to quantify
relative gene expression. 1CT of each sample was calculated by
subtracting its average CT value from the corresponding average
value of Rn18s. 11CT was calculated by subtracting the average
male control 1CT value from the average experimental 1CT
value. Fold increases in experimental samples relative to the male
control sample were calculated using the formula 2−11CT.
Western Blotting
Western blot analysis was performed as we described previously
(Tain et al., 2014). We used the following antibodies: for
angiotensin converting enzyme 2 (ACE2), rabbit anti-rat ACE2
(1:1000, overnight incubation; Santa Cruz Biotechnology, Santa
Cruz, California, USA); for angiotensin II type 2 receptor (AT2R),
rabbit anti-rat AT2R (1:250, overnight incubation; Santa Cruz
Biotechnology); for angiotensin (1–7) receptor MAS, a rabbit
anti-rat MAS antibody (1:1000, overnight incubation; Santa Cruz
Biotechnology). Bands of interest were visualized using enhanced
chemiluminescence reagents (PerkinElmer, Waltham,MA, USA)
and quantified by densitometry (Quantity One Analysis software;
Bio-Rad), as integrated optical density (IOD) after subtraction of
background. The IOD was factored for Ponceau red staining to
correct for any variations in total protein loading. The protein
abundance was represented as IOD/PonS.
Statistical Analysis
All data are expressed as mean ± SEM. Parameters were
compared using two-way ANOVA followed by a Tukey’s post
hoc test for multiple comparisons. Blood pressures were analyzed
by three-way ANOVA, with maternal high-fructose, sex, and
aliskiren administration as factors, results and interactions
were presented. A P-value < 0.05 was considered statistically
significant. All analyses were performed using the Statistical
Package for the Social Sciences (SPSS) software (Chicago, IL,
USA).
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TABLE 1 | Body and kidney weights in the offspring at 12 weeks of age.
Groups Controls HF HF+Aliskiren P-value
Sex Aliskiren S × A
Body weight (g) Male 458 ± 11 520± 18 483±10 <0.01 0.328 0.616
Female 262 ± 5 280± 10 254±6
Left kidney weight (g) Male 2 ± 0.05 1.84± 0.08 1.98±0.05 <0.01 0.743 0.099
Female 1.12 ± 0.04 1.15± 0.04 1.04±0.05
Left kidney weight/100 g body weight Male 0.44 ± 0.01 0.35± 0.01 0.41±0.01 0.487 0.802 0.306
Female 0.42 ± 0.01 0.41± 0.01 0.41±0.01
HF, offspring exposed to maternal high-fructose (HF) intake; HF + Aliskiren, offspring exposed to maternal HF intake plus postnatal aliskiren administration; S × A, interaction of sex ×
aliskiren; N (pups/litters) = 7/4 per group.
RESULTS
There were no differences in the litter size (control = 11.3 ± 0.7;
HF = 11.9 ± 0.9) and ratio of male-to-female pups (control vs.
HF = 1.09 vs. 0.94). Pup mortality rate was 0% in each group.
As shown in Table 1, HF diet did not significantly affect kidney
weight of either sex. There was a significant effect of sex on the
body and kidney weights (both Psex < 0.01), but not the kidney
weight-to-body weight ratio. There was little measureable effect
of aliskiren administration on body weight, kidney weight, and
the kidney weight-to-body weight ratio in the male or female
offspring.
As shown in Figure 1, the systolic blood pressures (SBP) was
lower in the female offspring compared to male offspring (Psex <
0.01). The SBP of HF exposure groups were significantly higher
than those in the control groups in both sexes from 8 to 12 weeks
of age (PHF < 0.01). Aliskiren administration reduced SBP in
male and female offspring exposed to maternal HF intake at 8
weeks (PAlis < 0.01) and 12 weeks of age (PAlis = 0.01). However,
time-dependent effect of aliskiren administration on SBP is sex-
specific, in that the effect after stopping treatment at 4 weeks
persists up to 12 weeks in the females, but disappears between
8 and 12 weeks in the males.
We next analyzed differential gene expression in the kidney
induced by maternal HF intake. The mappability of genes in
each group compared to the rat reference genome was 78.34%
for MC, 79.18% for FC, 77.32% for MHF, and 77.84% for FHF,
respectively. Among the differential expressed genes (DEGs), a
total of 11 genes (1 up- and 10 down-regulated genes by MHF
vs. MC, Supplementary Table 2) met the selection criteria of (i)
genes that changed by FPKM> 0.3 and (ii) minimum of twofold
difference in normalized read counts between group. As shown
in Supplementary Table 3, a total of 147 DEGs (92 up- and 55
down-regulated genes by FHF vs. FC) were noted in response
to maternal HF exposure in female offspring. Among them, 7
genes, Slc6a19, Kcnj15, Lrp2, Dgkg, Slc4a4, Slc15a1, and Cubn,
were shared (Figure 2). We next used DAVID v6.7 [17] to find
functionally related gene groups. We observed that only one
KEGG pathway related to HF-induced DEGs in the kidneys is
oxidative phosphorylation (P = 0.015 and Benjamini value =
0.62). In addition, we found 3 HF-induced DEGs, namely Abat,
FIGURE 1 | Effect of maternal high-fructose (HF) and aliskiren on
systolic blood pressure in male and female offspring. N (pups/litters) =
7/4 per group; Alis = aliskiren; S × A = interaction of sex × aliskiren.
Agtr1b, and Hmox1, were related to regulation of blood pressure
(GO:0008271).
Given that one HF-induced DEG with at least twofold
difference between FHF vs. FC was Agtr1b (fold change
[FC] = 4.37) (Figure 3A), and that RAS is involved in
programmed hypertension, we next investigated components of
RAS to elucidate underlying mechanisms related to programmed
hypertension. Our NGS data demonstrated that a total of 3 genes,
namely Ren (FC = 2.07), Agt (FC = 2.6), and Mas1 (FC = 2.71)
were differentially expressed between the MHF and MC group
(Table 2). However, maternal HF intake altered fold changes of
4 RAS genes, Ace (FC = 0.31), Ace2 (FC = 2.02), Agtr1b (FC =
4.37), andMas1 (FC= 2.77) between the FHF vs. FC group.
Next, we evaluated the renal mRNA expression of RAS
components at 12 weeks of age (Figure 3). In females, mRNA
expression of Agt (F = 232.4; Psex < 0.01, Figure 3C), Ace (F
= 43; Psex <0.01, Figure 3D), and Ace2 (F = 18.8; Psex < 0.01,
Figure 3E) in the kidney were lower than those in male offspring.
Renal Agtr1 mRNA expression was higher in female compared
to male offspring (F = 95.2; Psex < 0.01, Figure 3F). Aliskiren
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FIGURE 2 | Venn diagram depicting unique and shared (overlapping
circles) sets of differential expressed genes (DEGs) between females
(FHF vs. FC, white circle) and males (MHF vs. MC, gray circle). A total of
7 combined DEGs are listed in the lower panel.
TABLE 2 | Fold changes in genes in renin-angiotensin system in the
kidney of offspring at 1 week of age exposed to maternal high-fructose
intake (HF).
Gene ID Gene
symbol
MHF
/MC
FHF
/FC
MC
/FC
MHF
/FHF
ENSRNOG00000002937 Ren 2.07 0.75 0.45 1.25
ENSRNOG00000003858 Atp6ap2 1.29 1.45 1.09 0.97
ENSRNOG00000018445 Agt 2.60 1.37 0.68 1.28
ENSRNOG00000007467 Ace 0.77 0.31 0.40 0.98
ENSRNOG00000031665 Ace2 0.96 2.02 1.95 0.93
ENSRNOG00000018346 Agtr1a 1.55 1.74 1.14 1.02
ENSRNOG00000010640 Agtr1b 1.49 4.37 3.07 1.04
ENSRNOG00000014971 Mas1 2.71 2.77 2.14 2.09
Significant results are highlighted in bold. N = 3 per group.
administration after HF intake significantly increased the renal
mRNA expression of Ace (F = 9.8; PAlis < 0.01, Figure 3D). This
change was not associated with a sex-specific effect. In renalAgtr2
mRNA expression, post hoc tests showed a significant difference
between MC and MHF groups, and between FC and FHF+A
groups. Furthermore, we analyzed the protein levels of ACE2,
AT2R, and MAS in the offspring kidney (Figure 4) and found
that aliskiren administration significantly increased the renal
levels of ACE2 in the female offspring exposed to maternal HF
intake (F = 4.2; PSxA = 0.043; Figure 4B). Renal protein levels of
AT2R (F = 7.1; PAlis = 0.012) and MAS (F = 9.8; PAlis = 0.004)
were significantly higher in aliskiren treated offspring than those
exposed to HF. In renal ACE2 and MAS protein level, significant
differences were observed between FC and FHF+A groups.
DISCUSSION
This study provides insight into a novel mechanism by which
aliskiren administration prevents the maternal HF-induced
programmed hypertension in female adult offspring. The key
findings are as follows: (1) maternal HF intake induces
programmed hypertension in 12-week-old offspring of both
sexes, (2) maternal HF intake induces a greater change in renal
transcriptome in females than males at 1 week of age, (3) renal
mRNA expression of the RAS components in differ betweenmale
and female offspring, (4) aliskiren administration during early
postnatal life prevents HF-induced programmed hypertension
in both sexes of adult offspring and (5) aliskiren administration
increased ACE2 and MAS protein levels in female kidneys
exposed to maternal HF intake.
Despite the marked hypertensive effects of HF in adults
(Johnson et al., 2007; Tran et al., 2009), very few studies have
considered its effects on BP when fed to pregnant dams and,
subsequently, to their adult offspring (Tain et al., 2014, 2015c,d;
Gray et al., 2016), especially in regard to renal programming
(Tain et al., 2015d). In support of maternal HF eliciting renal
programming and programmed hypertension in male offspring
(Tain et al., 2014, 2015d), our study demonstrated that maternal
HF induced hypertension in adult offspring of both sexes. To
the best of our knowledge, the present study is the first to show
that the renin inhibitor, aliskiren, during early postnatal life can
prevent the development of hypertension in both sexes of adult
offspring exposed to maternal HF intake. It is consistent with
previous reports showing that early blockade of RAS prevents
programmed hypertension in a variety of programming models
(Sherman and Langley-Evans, 1998, 2000; Tain et al., 2011; Hsu
et al., 2015). Interestingly, the time-dependent effect of early
aliskiren on SBP is sex-specific, in that the effect after stopping
treatment at 4 weeks persists up to 12 weeks in the females, but
disappears between 8 and 12 weeks in the males. It has been
shown that deprogramming of hypertension appears to diminish
in male spontaneously hypertensive rats (SHR) while it persists
in female SHR (Koeners et al., 2007), and this observation was
supported by our findings demonstrating that the reduction of
SBPs by aliskiren administration persisted longer in female than
inmale adult offspring. These findings suggest thatmale offspring
are less amenable to reversing developmental programming of
hypertension.
In line with our previous male-only study (Tain et al.,
2015d), our NGS data illustrated that maternal HF intake
altered renal transcriptome of both sexes at 1 week of age, with
female offspring being more fructose-sensitive. Although sex
differences have been observed in developmental programming
of hypertension (Sandberg and Ji, 2012; Aiken and Ozanne,
2013), our study is the first to show sex differences of HF-
induced changes with a focus on renal transcriptome. Very few
studies have investigated sex-specifically transcriptomic change
in response to maternal diet. Our NGS data demonstrated
that maternal HF intake caused greater changes of renal
transcriptome in females thanmales at 1 week of age. This finding
is consistent with previous studies showing thatmore genes in the
placenta were affected in females than in males under different
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FIGURE 3 | Effects of maternal high-fructose (HF) and aliskiren administration on gene expression of renin-angiotensin system (RAS) components. (A)
Ren, (B) Atp6ap2, (C) Agt, (D) Ace, (E) Ace2, (F) Agtr1, (G) Agtr2, and (H) Mas1 in male and female offspring kidneys at 12 weeks of age. N (pups/litters) = 7/4 per
group; *P < 0.05 vs. respective control.
maternal diets (Mao et al., 2010; Cox et al., 2013). The authors
suggested that the increased female sensitivity to maternal diet
might buffer the deleterious effects of such diets to protect the
female fetuses, leading to a better adaptation and less impact
of programming in adulthood. This concept is supported by
our data showing that aliskiren administration provides better
protection against hypertension programmed by maternal HF
in female than male offspring with a greater reactivity of female
renal transcriptome to maternal HF.
We observed 7 DEGs, Slc6a19, Slc4a4, Slc15a1, Kcnj15, Lrp2,
Dgkg, and Cubn, that were shared by both sexes in response to
HF exposure. Defects in three of these genes, Slc6a19, Slc4a4, and
Lrp2 have been linked to hypertension (Yang et al., 2012; Pinto
et al., 2013; Sung et al., 2015). Slc6a19 gene encodes an amino acid
transporter B0AT1. Slc4a4 gene encodes a sodium bicarbonate
cotransporter (NBC) involved in the regulation of bicarbonate
secretion. Lrp2 gene encodes the multiligand receptor megalin.
Further studies are needed to determine whether these genes are
common genes in the development of hypertension in different
programming models.
In addition, we identified three DEGs, Abat, Hmox1,
and Agtr1b, related to the regulation of BP that showed
sex differences in expression. Abat gene encodes for 4-
aminobutyrate aminotransferase is responsible for catabolism
of gamma-aminobutyric acid (GABA), an important inhibitory
neurotransmitter. Hmox1 encodes for heme oxygenase 1; it is
critical for redox balance and is associated with hypertension.
Agtr1b encodes for angiotensin II receptor, type 1b. It is
noteworthy that maternal HF intake has a distinct sex-specific
effect on the renal RAS system at 1 week of age, immediately
after the completion of nephrogenesis: Maternal HF up-regulated
Ren (FC = 2.07) and Agt (FC = 2.6) in male offspring, while
up-regulated Ace2 (FC = 2.02) and Mas1 (FC = 2.77) in female
offspring.
Alteration of RAS in the kidneys has been considered to be an
important mechanism for the fetal programming of hypertension
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FIGURE 4 | Representative western blots (A) showed angiotensin-converting enzyme 2 (ACE2) (90 kDa), angiotensin II type 2 receptor (AT2R) (50 kDa),
and angiotensin (1–7) receptor MAS (37 kDa) bands in offspring rats at 12 weeks of age. Relative abundance of renal cortical (B) ACE2, (C) AT2R, and (D)
MAS as quantified. N (pups/litters) = 7/4 per group; *P < 0.05 vs. respective control.
(Paixão and Alexander, 2013). Several RAS components can be
epigenetically regulated in a maternal low protein diet model
of programmed hypertension (Bogdarina et al., 2007). Despite
evidence supporting sex differences in the responsiveness to
Ang-(1–7) (Chappell et al., 2014), the mechanism underlying
the sex-dependent effects of ACE2-Ang-(1–7)-MAS axis in HF-
induced programmed hypertension have not been explored.
Our results showed that aliskiren administration increased
ACE2 and MAS protein levels in female kidneys exposed to
maternal HF intake, which implies that the protective effect of
aliskiren in hypertension programmed by maternal HF intake
in females is related to the activation of ACE2-Ang-(1–7)-MAS
pathway. Importantly, ACE2 appears to alter AT2R and the
angiotensin (1–7) receptor MAS in a way that opposes the
development of hypertension (Fraga-Silva et al., 2013). Thus,
one might expect aliskiren administration during early postnatal
life to upregulate AT2R and MAS, thereby affecting the RAS
in a way that opposes the development of hypertension in
female adult offspring. Although we observed that renal Agt,
Ace, Ace2, and Agtr1 expression are sex-specific, only Ace
was significantly altered by akiskiren administration without a
sex-specific effect. Consistent with a previous report showing
that hepatic Agt mRNA levels were lower in female than in
male spontaneously hypertensive rats (Chen et al., 1992), our
data showed that renal Agt mRNA expression was lower in
female than that in male SD offspring. Whether sex-specific
expression of RAS components is organ-specific or species-
specific awaits further evaluation. Given that Ace2 and Agtr2
are X-chromosome-located RAS genes (Te Riet et al., 2015),
whether sex chromosomes influence their expression to protect
females against HF-induced programmed hypertension deserves
further clarification. Our findings in conjunction with others
suggest sex-dependent renal programming within the RAS may,
in part, underlie the programmed hypertension associated with
HF exposure and reprogramming strategy.
One limitation in this study is that we did not analyze
other organs involved in BP regulation, such as the brain and
vasculature. A second limitation is that we did not examine renal
transcriptome in different developmental windows. It is possible
that epigenetic regulation occurs early during fetal development,
and our NGS results might be a secondary phenomenon. Third,
we did not conduct theMC+Aliskiren and FC+Aliskiren groups.
Thus, the long-term effects of aliskiren on normal controls
deserve further evaluation.
In conclusion, maternal HF induces sex-specific renal
programming in the offspring. Although HF programs
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hypertension in the offspring of both sexes, different regulation
of RAS after early aliskiren administration sex-specifically
alleviates hypertension in adult offspring. It is thought that by
exploration of sex differences in the susceptibility to hypertension
programmed by maternal HF consumption, and of the adaptive
effects that alleviate it might lead to the development of strategies
to prevent programmed hypertension in both sexes.
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